SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-300558
Filing Date
2021-10-18
Accepted
2021-10-18 07:45:57
Documents
14
Period of Report
2021-10-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d66778d8k.htm   iXBRL 8-K 39084
2 EX-10.1 d66778dex101.htm EX-10.1 61881
3 EX-99.1 d66778dex991.htm EX-99.1 10215
  Complete submission text file 0001193125-21-300558.txt   272236

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cgem-20211015.xsd EX-101.SCH 2916
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cgem-20211015_lab.xml EX-101.LAB 20374
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cgem-20211015_pre.xml EX-101.PRE 12771
7 EXTRACTED XBRL INSTANCE DOCUMENT d66778d8k_htm.xml XML 3718
Mailing Address ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142 617-410-4650
Cullinan Oncology, Inc. (Filer) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39856 | Film No.: 211327338
SIC: 2836 Biological Products, (No Diagnostic Substances)